カテゴリー： Market Monitor Global, 世界, 医療/バイオ

組換えヒト上皮成長因子の世界市場見通し2023年-2029年

◆英語タイトル：Recombinant Human Epidermal Growth Factor Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2509）

◆商品コード：MMG23FB2509
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の組換えヒト上皮成長因子市場規模と予測を収録しています。・世界の組換えヒト上皮成長因子市場：売上、2018年-2023年、2024年-2029年
・世界の組換えヒト上皮成長因子市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の組換えヒト上皮成長因子市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「20,000 IU/ボトル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

組換えヒト上皮成長因子のグローバル主要企業は、Promega、STEMCELL Technologies、Abbkine、Shanghai Haohai Biological Technology、QED Bioscience、Proteintech、Corning、BioLegendなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、組換えヒト上皮成長因子のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の組換えヒト上皮成長因子市場：タイプ別、2018年-2023年、2024年-2029年
世界の組換えヒト上皮成長因子市場：タイプ別市場シェア、2022年
・20,000 IU/ボトル、50,000 IU/ボトル、75,000 IU/ボトル、100,000 IU/ボトル

世界の組換えヒト上皮成長因子市場：用途別、2018年-2023年、2024年-2029年
世界の組換えヒト上皮成長因子市場：用途別市場シェア、2022年
・糖尿病性足潰瘍、床ずれ、慢性下肢潰瘍、血管潰瘍、その他

世界の組換えヒト上皮成長因子市場：地域・国別、2018年-2023年、2024年-2029年
世界の組換えヒト上皮成長因子市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における組換えヒト上皮成長因子のグローバル売上、2018年-2023年
・主要企業における組換えヒト上皮成長因子のグローバル売上シェア、2022年
・主要企業における組換えヒト上皮成長因子のグローバル販売量、2018年-2023年
・主要企業における組換えヒト上皮成長因子のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Promega、STEMCELL Technologies、Abbkine、Shanghai Haohai Biological Technology、QED Bioscience、Proteintech、Corning、BioLegend

*************************************************************

・調査・分析レポートの概要
組換えヒト上皮成長因子市場の定義
市場セグメント
世界の組換えヒト上皮成長因子市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の組換えヒト上皮成長因子市場規模
世界の組換えヒト上皮成長因子市場規模：2022年 VS 2029年
世界の組換えヒト上皮成長因子市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの組換えヒト上皮成長因子の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の組換えヒト上皮成長因子製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：20,000 IU/ボトル、50,000 IU/ボトル、75,000 IU/ボトル、100,000 IU/ボトル
組換えヒト上皮成長因子のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：糖尿病性足潰瘍、床ずれ、慢性下肢潰瘍、血管潰瘍、その他
組換えヒト上皮成長因子の用途別グローバル売上・予測

・地域別市場分析
地域別組換えヒト上皮成長因子市場規模 2022年と2029年
地域別組換えヒト上皮成長因子売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Promega、STEMCELL Technologies、Abbkine、Shanghai Haohai Biological Technology、QED Bioscience、Proteintech、Corning、BioLegend
...

Recombinant human epidermal growth factor has potential epithelial regeneration and cytoprotective activities. When applied topically, recombinant human epidermal growth factor (rhEGF) stimulates epithelial cell proliferation, differentiation, and migration, thereby accelerating epithelial regeneration and wound healing.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Epidermal Growth Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Epidermal Growth Factor. This report contains market size and forecasts of Recombinant Human Epidermal Growth Factor in global, including the following market information:
Global Recombinant Human Epidermal Growth Factor Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Human Epidermal Growth Factor Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Recombinant Human Epidermal Growth Factor companies in 2022 (%)
The global Recombinant Human Epidermal Growth Factor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
20,000 IU/Bottle Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Epidermal Growth Factor include Promega, STEMCELL Technologies, Abbkine, Shanghai Haohai Biological Technology, QED Bioscience, Proteintech, Corning and BioLegend, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Epidermal Growth Factor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Recombinant Human Epidermal Growth Factor Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Human Epidermal Growth Factor Market Segment Percentages, by Type, 2022 (%)
20,000 IU/Bottle
50,000 IU/Bottle
75,000 IU/Bottle
100,000 IU/Bottle
Global Recombinant Human Epidermal Growth Factor Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Human Epidermal Growth Factor Market Segment Percentages, by Application, 2022 (%)
Diabetic Foot Ulcer
Bedsore
Chronic Leg Ulcers
Vascular Ulcer
Others
Global Recombinant Human Epidermal Growth Factor Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Human Epidermal Growth Factor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Epidermal Growth Factor revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Human Epidermal Growth Factor revenues share in global market, 2022 (%)
Key companies Recombinant Human Epidermal Growth Factor sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Human Epidermal Growth Factor sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Promega
STEMCELL Technologies
Abbkine
Shanghai Haohai Biological Technology
QED Bioscience
Proteintech
Corning
BioLegend
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Epidermal Growth Factor, market overview.
Chapter 2: Global Recombinant Human Epidermal Growth Factor market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Human Epidermal Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Epidermal Growth Factor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Human Epidermal Growth Factor capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Epidermal Growth Factor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Epidermal Growth Factor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Epidermal Growth Factor Overall Market Size
2.1 Global Recombinant Human Epidermal Growth Factor Market Size: 2022 VS 2029
2.2 Global Recombinant Human Epidermal Growth Factor Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Human Epidermal Growth Factor Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Human Epidermal Growth Factor Players in Global Market
3.2 Top Global Recombinant Human Epidermal Growth Factor Companies Ranked by Revenue
3.3 Global Recombinant Human Epidermal Growth Factor Revenue by Companies
3.4 Global Recombinant Human Epidermal Growth Factor Sales by Companies
3.5 Global Recombinant Human Epidermal Growth Factor Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Human Epidermal Growth Factor Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Human Epidermal Growth Factor Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Epidermal Growth Factor Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Epidermal Growth Factor Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Epidermal Growth Factor Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Recombinant Human Epidermal Growth Factor Market Size Markets, 2022 & 2029
4.1.2 20,000 IU/Bottle
4.1.3 50,000 IU/Bottle
4.1.4 75,000 IU/Bottle
4.1.5 100,000 IU/Bottle
4.2 By Type – Global Recombinant Human Epidermal Growth Factor Revenue & Forecasts
4.2.1 By Type – Global Recombinant Human Epidermal Growth Factor Revenue, 2018-2023
4.2.2 By Type – Global Recombinant Human Epidermal Growth Factor Revenue, 2024-2029
4.2.3 By Type – Global Recombinant Human Epidermal Growth Factor Revenue Market Share, 2018-2029
4.3 By Type – Global Recombinant Human Epidermal Growth Factor Sales & Forecasts
4.3.1 By Type – Global Recombinant Human Epidermal Growth Factor Sales, 2018-2023
4.3.2 By Type – Global Recombinant Human Epidermal Growth Factor Sales, 2024-2029
4.3.3 By Type – Global Recombinant Human Epidermal Growth Factor Sales Market Share, 2018-2029
4.4 By Type – Global Recombinant Human Epidermal Growth Factor Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Recombinant Human Epidermal Growth Factor Market Size, 2022 & 2029
5.1.2 Diabetic Foot Ulcer
5.1.3 Bedsore
5.1.4 Chronic Leg Ulcers
5.1.5 Vascular Ulcer
5.1.6 Others
5.2 By Application – Global Recombinant Human Epidermal Growth Factor Revenue & Forecasts
5.2.1 By Application – Global Recombinant Human Epidermal Growth Factor Revenue, 2018-2023
5.2.2 By Application – Global Recombinant Human Epidermal Growth Factor Revenue, 2024-2029
5.2.3 By Application – Global Recombinant Human Epidermal Growth Factor Revenue Market Share, 2018-2029
5.3 By Application – Global Recombinant Human Epidermal Growth Factor Sales & Forecasts
5.3.1 By Application – Global Recombinant Human Epidermal Growth Factor Sales, 2018-2023
5.3.2 By Application – Global Recombinant Human Epidermal Growth Factor Sales, 2024-2029
5.3.3 By Application – Global Recombinant Human Epidermal Growth Factor Sales Market Share, 2018-2029
5.4 By Application – Global Recombinant Human Epidermal Growth Factor Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Recombinant Human Epidermal Growth Factor Market Size, 2022 & 2029
6.2 By Region – Global Recombinant Human Epidermal Growth Factor Revenue & Forecasts
6.2.1 By Region – Global Recombinant Human Epidermal Growth Factor Revenue, 2018-2023
6.2.2 By Region – Global Recombinant Human Epidermal Growth Factor Revenue, 2024-2029
6.2.3 By Region – Global Recombinant Human Epidermal Growth Factor Revenue Market Share, 2018-2029
6.3 By Region – Global Recombinant Human Epidermal Growth Factor Sales & Forecasts
6.3.1 By Region – Global Recombinant Human Epidermal Growth Factor Sales, 2018-2023
6.3.2 By Region – Global Recombinant Human Epidermal Growth Factor Sales, 2024-2029
6.3.3 By Region – Global Recombinant Human Epidermal Growth Factor Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Recombinant Human Epidermal Growth Factor Revenue, 2018-2029
6.4.2 By Country – North America Recombinant Human Epidermal Growth Factor Sales, 2018-2029
6.4.3 US Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.4.4 Canada Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.4.5 Mexico Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Recombinant Human Epidermal Growth Factor Revenue, 2018-2029
6.5.2 By Country – Europe Recombinant Human Epidermal Growth Factor Sales, 2018-2029
6.5.3 Germany Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.5.4 France Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.5.5 U.K. Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.5.6 Italy Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.5.7 Russia Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.5.9 Benelux Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Recombinant Human Epidermal Growth Factor Revenue, 2018-2029
6.6.2 By Region – Asia Recombinant Human Epidermal Growth Factor Sales, 2018-2029
6.6.3 China Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.6.4 Japan Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.6.5 South Korea Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.6.7 India Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Recombinant Human Epidermal Growth Factor Revenue, 2018-2029
6.7.2 By Country – South America Recombinant Human Epidermal Growth Factor Sales, 2018-2029
6.7.3 Brazil Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.7.4 Argentina Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Recombinant Human Epidermal Growth Factor Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Recombinant Human Epidermal Growth Factor Sales, 2018-2029
6.8.3 Turkey Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.8.4 Israel Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
6.8.6 UAE Recombinant Human Epidermal Growth Factor Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Promega
7.1.1 Promega Company Summary
7.1.2 Promega Business Overview
7.1.3 Promega Recombinant Human Epidermal Growth Factor Major Product Offerings
7.1.4 Promega Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.1.5 Promega Key News & Latest Developments
7.2 STEMCELL Technologies
7.2.1 STEMCELL Technologies Company Summary
7.2.2 STEMCELL Technologies Business Overview
7.2.3 STEMCELL Technologies Recombinant Human Epidermal Growth Factor Major Product Offerings
7.2.4 STEMCELL Technologies Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.2.5 STEMCELL Technologies Key News & Latest Developments
7.3 Abbkine
7.3.1 Abbkine Company Summary
7.3.2 Abbkine Business Overview
7.3.3 Abbkine Recombinant Human Epidermal Growth Factor Major Product Offerings
7.3.4 Abbkine Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.3.5 Abbkine Key News & Latest Developments
7.4 Shanghai Haohai Biological Technology
7.4.1 Shanghai Haohai Biological Technology Company Summary
7.4.2 Shanghai Haohai Biological Technology Business Overview
7.4.3 Shanghai Haohai Biological Technology Recombinant Human Epidermal Growth Factor Major Product Offerings
7.4.4 Shanghai Haohai Biological Technology Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.4.5 Shanghai Haohai Biological Technology Key News & Latest Developments
7.5 QED Bioscience
7.5.1 QED Bioscience Company Summary
7.5.2 QED Bioscience Business Overview
7.5.3 QED Bioscience Recombinant Human Epidermal Growth Factor Major Product Offerings
7.5.4 QED Bioscience Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.5.5 QED Bioscience Key News & Latest Developments
7.6 Proteintech
7.6.1 Proteintech Company Summary
7.6.2 Proteintech Business Overview
7.6.3 Proteintech Recombinant Human Epidermal Growth Factor Major Product Offerings
7.6.4 Proteintech Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.6.5 Proteintech Key News & Latest Developments
7.7 Corning
7.7.1 Corning Company Summary
7.7.2 Corning Business Overview
7.7.3 Corning Recombinant Human Epidermal Growth Factor Major Product Offerings
7.7.4 Corning Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.7.5 Corning Key News & Latest Developments
7.8 BioLegend
7.8.1 BioLegend Company Summary
7.8.2 BioLegend Business Overview
7.8.3 BioLegend Recombinant Human Epidermal Growth Factor Major Product Offerings
7.8.4 BioLegend Recombinant Human Epidermal Growth Factor Sales and Revenue in Global (2018-2023)
7.8.5 BioLegend Key News & Latest Developments
8 Global Recombinant Human Epidermal Growth Factor Production Capacity, Analysis
8.1 Global Recombinant Human Epidermal Growth Factor Production Capacity, 2018-2029
8.2 Recombinant Human Epidermal Growth Factor Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Epidermal Growth Factor Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Epidermal Growth Factor Supply Chain Analysis
10.1 Recombinant Human Epidermal Growth Factor Industry Value Chain
10.2 Recombinant Human Epidermal Growth Factor Upstream Market
10.3 Recombinant Human Epidermal Growth Factor Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Epidermal Growth Factor Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 組換えヒト上皮成長因子の世界市場見通し2023年-2029年(Recombinant Human Epidermal Growth Factor Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

組換えヒト上皮成長因子の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp